OraltagActive Ingredient(s): Iohexol
FDA Approved: * March 26, 2015
Pharm Company: * INTERPHARMA PRAHA AS
Category: Diagnostic Aid
Iohexol, sold under the trade name Omnipaque among others, is a contrast agent used for X-ray imaging. This includes when visualizing arteries, veins, ventricles of the brain, the urinary system, and joints, as well as during computed tomography (CT scan). It is given by mouth, injection into a vein, or into a body cavity. Side effects include vomiting, skin flushing, headache, itchiness, kidney problems, and low blood pressure.[... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.